Alzheimer’s Disease affects 5.4M individuals in the US and 35M worldwide according to the Alzheimer’s Association. As the overall population ages, the number of cases is expect to grow. An effective treatment for this devastating disease is needed.
We believe such a treatment has been discovered. ADispell has novel, patented technology that has exciting promise. Recent results from animal experiments have provided exciting evidence that some of our compounds could halt, and perhaps reverse the deterioration to brain neurons that cause Alzheimer’s and other diseases of cognition loss. The technology is believed to have potential favorable effect on other cognitive loss disease, behavior conditions, and even drug addiction. Find out more.